Clinical pharmacokinetics of morphine
- PMID: 14635822
- DOI: 10.1080/j354v16n04_02
Clinical pharmacokinetics of morphine
Abstract
Morphine, the most widely used mu-opioid analgesic for acute and chronic pain, is the standard against which new analgesics are measured. A thorough understanding of the pharmacokinetics of morphine is required in order to safely and effectively use this analgesic in a wide variety of patients with different levels of organ function. A MEDLINE search was conducted to identify literature published between 1966 and January 2002 relevant to the pharmacokinetics of morphine. These publications were reviewed and the literature summarized regarding unique and clinically important elements of morphine disposition relative to its parenteral administration (including intravenous, intramuscular, subcutaneous, epidural and intrathecal administration), absorption profile (immediate release, controlled release, and sublingual/buccal, and rectal administration), distribution, and its metabolism/excretion. Special populations, including infants, elderly, and those with renal/liver failure, have a unique morphine pharmacokinetic profile that must be taken into account in order to maximize analgesic efficacy and reduce the risk of adverse events.
Similar articles
-
The pharmacokinetics of oxycodone.J Pain Palliat Care Pharmacother. 2004;18(4):17-30. doi: 10.1300/j354v18n04_03. J Pain Palliat Care Pharmacother. 2004. PMID: 15760805 Review.
-
Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide.Clin Pharmacol Ther. 1990 Jan;47(1):12-9. doi: 10.1038/clpt.1990.2. Clin Pharmacol Ther. 1990. PMID: 2295214
-
Pharmacokinetics of methadone.J Pain Palliat Care Pharmacother. 2005;19(4):13-24. J Pain Palliat Care Pharmacother. 2005. PMID: 16431829 Review.
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
-
Sustained relief of chronic pain. Pharmacokinetics of sustained release morphine.Clin Pharmacokinet. 1998 Sep;35(3):173-90. doi: 10.2165/00003088-199835030-00002. Clin Pharmacokinet. 1998. PMID: 9784932 Review.
Cited by
-
A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients.Clin Pharmacokinet. 2017 Jul;56(7):733-746. doi: 10.1007/s40262-016-0471-7. Clin Pharmacokinet. 2017. PMID: 27815868 Free PMC article. Clinical Trial.
-
Pain Therapy Guided by Purpose and Perspective in Light of the Opioid Epidemic.Front Psychiatry. 2018 Apr 23;9:119. doi: 10.3389/fpsyt.2018.00119. eCollection 2018. Front Psychiatry. 2018. PMID: 29740351 Free PMC article. Review.
-
Pediatric Oncology: Managing Pain at the End of Life.Paediatr Drugs. 2016 Jun;18(3):161-80. doi: 10.1007/s40272-016-0168-2. Paediatr Drugs. 2016. PMID: 26951239 Review.
-
Pharmacokinetics, metabolite profiling, safety and tolerability of YZJ-4729 tartrate, a novel G protein-biased μ-opioid receptor agonist, in healthy Chinese subjects.Front Pharmacol. 2024 Jan 9;14:1295319. doi: 10.3389/fphar.2023.1295319. eCollection 2023. Front Pharmacol. 2024. PMID: 38264529 Free PMC article.
-
Opioid Modulation of Value-Based Decision-Making in Healthy Humans.Neuropsychopharmacology. 2017 Aug;42(9):1833-1840. doi: 10.1038/npp.2017.58. Epub 2017 Mar 15. Neuropsychopharmacology. 2017. PMID: 28294136 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials